Bay Rivers Group’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-68,801
Closed -$1.66M 61
2022
Q3
$1.66M Sell
68,801
-458
-0.7% -$11.3K 1.66% 25
2022
Q2
$1.71M Sell
69,259
-1,361
-2% -$33.9K 1.52% 31
2022
Q1
$1.78M Sell
70,620
-145
-0.2% -$3.74K 1.28% 31
2021
Q4
$1.87M Buy
70,765
+2,514
+4% +$66.8K 1.14% 36
2021
Q3
$1.83M Buy
68,251
+3,303
+5% +$89.1K 1.25% 31
2021
Q2
$1.75M Buy
64,948
+3,378
+5% +$91.1K 1.24% 31
2021
Q1
$1.65M Buy
61,570
+11,413
+23% +$309K 1.28% 30
2020
Q4
$1.37M Buy
50,157
+29,201
+139% +$794K 1.15% 33
2020
Q3
$569K Buy
+20,956
New +$569K 0.54% 47

Other funds holding IBDQ

Bay Rivers Group's IBDQ Position: Q4 2022 in Review

Bay Rivers Group sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2022, closing a stake of 68,801 shares — an estimated $1.66M sold.

Bay Rivers Group first reported a position in IBDQ in Q3 2020 and held it in 9 quarters. The position peaked at $1.87M in Q4 2021. 233 funds tracked by Wall St. Rank hold IBDQ as of Q4 2022.

  • Bay Rivers Group reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2022 after selling out during the quarter.
  • Bay Rivers Group sold 68,801 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2022, an estimated $1.66M.
  • Bay Rivers Group first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q3 2020 and held it in 9 quarters.
  • Bay Rivers Group's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $1.87M in Q4 2021.
  • 233 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2022.

Based on Bay Rivers Group's 13F filing for Q4 2022, filed 17 Jan 2023.